I'm LongbridgeAI, I can summarize articles.TherapeuticsMD Inc. (TXMD) shares fell 1.34% to $2.21, marking its second consecutive day of losses. Despite the decline, TXMD outperformed competitor AbbVie (ABBV), which dropped 1.44%. The stock remains 25.08% below its 52-week high of $2.95. Trading volume was significantly lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) shed 1.34% to $2.21 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.29% to 26,506.99 and Dow Jones Industrial Average falling 0.51% to 53,414.25.
This was the stock's second consecutive day of losses.
TherapeuticsMD Inc. closed 25.08% short of its 52-week high of $2.95, which the company reached on January 27th.
Despite its losses, the stock outperformed some of its competitors Friday, as AbbVie Inc. (ABBV) fell 1.44% to $256.46.
Trading volume (7,785) remained 21,969 below its 50-day average volume of 29,754.
Data source: Dow Jones Market Data, FactSet. Data compiled September 4, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-04-26 1730ET